IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335

Breast Cancer Research and Treatment

Volumn 54, Issue 1, 1999, Pages 11-23

  Oosterlaken Dijksterhuis, Marja A ^a   Kwant, Marijke M ^a   Slob, Adri ^a   Hellmén, Eva ^b   Mol, Jan A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Dog; IGF; IGFBP; Mammary mesenchymal cell line; Retinoic acid

Indexed keywords

INSULIN; RETINOIC ACID; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; DOG; DRUG MEGADOSE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GROWTH; MESENCHYME CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; STROMA CELL;

EID: 0032898606     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006107703745     Document Type: Article

References (48)

1. 1. Bostock DE: The prognosis following the surgical excision of canine mammary neoplasms. Eur J Cancer 11: 389-396, 1975
2. 2. Owen LN, Briggs MH: Contraceptive steroid toxicology in the beagle dog and its relevance to human carcinogenecity. Curr Med Res Opin 4: 309-329, 1976
3. 3. El Etreby MF, Gråf KJ: Effect of contraceptive steroids on mammary gland of female dog and its relevance to human carcinogenecity. Pharmacol Ther 5: 369-402, 1979
4. 4. Casey HW, Giles RC, Kwapien RP: Mammary neoplasms in animals. Pathologic aspects and the effect of contraceptive steroids. Recent Results. Cancer Res 66: 129-160, 1979
5. 5. Misdorp, W: Progestagens and mammary tumors in dogs and cats. Acta Endocrinol 125: 27-31, 1991
6. 6. Rutteman GR: Contraceptive steroids and the mammary gland: Is there a hazard? Insights from animals studies. Breast Cancer Res Treat 23: 29-41, 1992
7. 7. Concannon PW, Altszuler N, Hampshire J, Butler WB, Hansel W: Growth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegalic-like appearance during treatment with medroxy-progesterone acetate. Endocrinology 106: 1173-1177, 1980
8. 8. Rijnberk A, Eigenmann JE, Belshaw BE, Hampshire J, Altszuler N: Acromegaly associated with transient overproduction of growth hormone in a dog. J Am Vet Med Assoc 177: 534-537, 1980
9. 9. Eigenmann JE, Rijnberk A: Influence of medroxyprogesterone acetate (Provera) on plasma growth hormone levels and on carbohydrate metabolism: I. Studies in the ovariohysterectomized bitch. Acta Endocrinol 98: 599-602, 1981
10. 10. Selman PJ, Mol JA, Rutteman GR, Rijnberk A: Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134: 287-292, 1994
11. 11. Mol JA, van Garderen E, Selman PJ, Wolfswinkel J, Rijnberk A, Rutteman GR: Growth Hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 95: 2028-2034, 1995
12. 12. Daughaday WH, Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10: 68-91, 1989
13. 13. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-35, 1995
14. 14. Pekonen F, Nyman T, Ilvesmåki V, Partanen S: Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res 52: 5204-5207, 1992
15. 15. Figueroa JA, Jackson JG, McGuire WL, Krywicki RH, Yee, D: Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 52: 196-205, 1993
16. 16. McGuire SE, Hilsenbeck SG, Figueroa JA, Jackson JG, Yee D: Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues. Cancer Lett 77: 25-32, 1994
17. 17. Clemmons DR, Camacho-Hübner C, Coronado E, Osborne CK: Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 127: 2679-2686, 1990
18. 18. Jetten AM: In: Guroff, G (ed) Growth and Maturation Factors. Vol 3. Wiley, New York, 1985, pp. 252-293
19. 19. Fontana JA, Burroes-Mezu A, Clemmons DR, LeRoith D: Retinoid modulation of insulin-like growth factor binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 127: 1115-1122, 1991
20. 20. Adamo ML, Shao Z-M, Lanau F, Chen J-C, Clemmons DR, Roberts CT, LeRoith D, Fontana JA: Insulin-like growth factor-1 (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131: 1859-1867, 1992
21. 21. Sheikh MS, Shao Z-M, Hussain A, Clemmons DR, Chen J-C, Roberts CT, LeRoith D, Fontana JA: Regulation of insulin-like growth factor binding protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol 155: 556-567, 1993
22. 22. Sheikh MS, Shao Z-M, Hussain A, Chen J-C, Roberts CT, LeRoith D, Fontana JA: Retinoic acid and estrogen modulation of insulin-like growth factor binding protein-4 gene expression and the estrogen receptor status of human breast carcinoma cells. Biochem Biophys Res Commun 193: 1232-1238, 1993
23. 23. Haslam SZ: Stromal-epithelial interactions in normal and neoplastic mammary gland. Cancer Treat Res 53: 401-420, 1991
24. 24. Woodward TL, Xie JW, Haslam SZ: The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland. J Mam Gland Biol Neoplasia 3: 117-131, 1998
25. 25. Nap RC, Mol JA, Hazewinkel HAW: Age-related plasma concentrations of growth hormone and insulin-like growth factor in Great Dane pups on different levels of protein intake. Domestic Animal Endocrinol 10: 237-247, 1993
26. 26. Mol JA, Selman PJ, Sprang EPM, Oosterlaken-Dijksterhuis MA, van Neck JW: IGF and IGF binding protein in plasma and mammary tissue of dogs with progestin induced growth hormone excess. In: Effects of Progestin Administration in the Dog. Thesis, Chapter 9, Utrecht University, Utrecht, 1995
27. 27. van Zoelen EJJ, van Oostwaard TMJ, van der Saag PT, de Laat SW: Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor. J Cell Physiol 123: 151-160, 1985
28. 28. Knudsen BS, Harpel PC, Nachman RL: Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest 82: 1082-1089, 1987
29. 29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacterophage T4. Nature 227: 680-685, 1970
30. 30. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 1982
31. 31. Cohick WS, Clemmons DR: The insulin-like growth factors. Annu Rev Physiol 55: 131-153, 1993
32. 32. Rechler MM, Brown AL: Insulin-like growth factor binding proteins: gene structure and expression. Growth Regulation 2: 55-68, 1992
33. 33. Grellier P, Yee D, Gonzalez M, Abboud SL: Characterization of insulin-like growth factor binding proteins (IGFBP) and regulation of IGFBP-4 in bone marrow stromal cells. Br J Haematol 90: 249-257, 1995
34. 34. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG: Insulin-like growth factor binding proteins (IGFBPS) and their regulatory dynamics. Int J Biochem Cell Biol 28: 619-637, 1996
35. 35. Clemmons DR: Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8: 45-62, 1997
36. 36. Shemer J, Yaron A, Shao ZM, Sheikh MS, Fontana JA, LeRoith D, Roberts CT: Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid. J Clin Endocrinol Metab 77: 1246-1250, 1993
37. 37. Martin JL, Coverley JA, Pattison ST, Baxter RC: Insulin-like growth factor binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate differential effects of estradiol. Endocrinology 136: 1219-1226, 1995
38. 38. Martin JL, Coverley JA, Baxter RC: Regulation of immunoreactive insulin-like growth factor binding protein-6 in normal and transformed human fibroblasts. J Biol Chem 269: 11470-11477, 1994
39. 39. Dong Y, Canalis E: Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology 136: 2000-2006, 1995
40. 40. Zhou Y, Mohan S, Linkhart TA, Baylink DJ, Strong DD: Retinoic acid regulates insulin-like growth factor binding protein expression in human osteoblast cells. Endocrinology 137: 975-983, 1996
41. 41. Jones JI, Gockerman A, Busby WH, Camacho-Hübner C, Clemmons DR: Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121: 679-687, 1993
42. 42. Schmid C, Schlapfer I, Gosteli-Peter MA, Froesch ER, Zupf J: Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures. Am J Physiol 271: E1029-E1035, 1996
43. 43. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ: Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270: 20424-20431, 1995
44. 44. James PL, Stewart CE, Rotwein P: Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J Cell Biol 133: 683-693, 1996
45. 45. Reeve JG, Guadano A, Xiong J, Morgan J, Bleehen NM: Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-mediated autocrine growth in simian virus 40-transformed human fibroblasts. J Biol Chem 270: 135-142, 1995
46. 46. Verschure PJ, van Noorden CJF, van Marle J, van den Berg WB: Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes. Histochem J 28: 835-857, 1996
47. 47. Morales TI: Transforming growth factor-beta and insulin-like growth factor-1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid. Arch Biochem Biophys 315: 190-198, 1994
48. 48. Oh Y: IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res Treat 47: 283-293, 1998